Trending...
- Ryan J. Murphy Named as 2026 Irish Legal 100 Honoree
- Gahl Sasson Releases "Agents of Chaos & Angels of Change: The Astrology of 2027
- Tek84 Unveils New Brand Identity Built to Magnify What Security Officers Can Do
MALVERN, Pa.--(BUSINESS WIRE)--YPrime, LLC., a global leader in cloud-based eClinical solutions, announced today the launch of their fifth-generation electronic clinical outcome assessment (eCOA) platform. YPrime's newest platform features an improved user experience for patients, clinical investigators, sponsors, and CROs. This advanced technology enhances clinical trial efficiency, increases site satisfaction, and improves patient compliance. This release also ensures the delivery of cleaner data, streamlining the clinical trial data collection and approval process.
"With a 15-year track record as a technology leader, we are constantly innovating to help drive the digital transformation of clinical research," said YPrime Co-Founder and CEO Shawn Blackburn. "The rapid shift toward a more patient-centered approach to clinical trials is enabled by the strength of our eCOA platform."
More on The PennZone
Tailored for today's complex clinical trials, YPrime's platform helps patients remain engaged and compliant through straightforward design. Developed to integrate intelligently with other eClinical technologies and with the ability to move between devices, YPrime offers a customized solution with the necessary control and security that ensures accurate data collection from specification to submission.
"Real-time data access enhances project control for sponsors and empowers their decision-making," said Michael Hughes, senior vice president, product development. "With superior processing power and advanced security protections, clinical development teams can be assured that they'll receive continuous, high-quality data throughout the duration of the study."
About YPrime
YPrime's cloud-based technology streamlines clinical trial data collection and management. YPrime's eCOA and interactive response technology (IRT) platforms introduce greater speed, precision, and data quality to clinical trials. Our consulting services help clients simplify downstream processes, while moving faster and more efficiently to their next development milestone.
"With a 15-year track record as a technology leader, we are constantly innovating to help drive the digital transformation of clinical research," said YPrime Co-Founder and CEO Shawn Blackburn. "The rapid shift toward a more patient-centered approach to clinical trials is enabled by the strength of our eCOA platform."
More on The PennZone
- Pastor Carlton L. Aiken Sr. Celebrates 55 Years with "Sermonic Selections"
- J. Wes Seeks Jazz Musicians, Vocalists and Bands for Philadelphia Live Music Event
- NECP Promotes Chertova to Senior Business Analyst
- Security Industry Veteran Anthony Rumore Launches AegisLead to Help Security Companies Find Business and Manage Growth
- Charlie Shaw and Patrick Carragher win SEO Agency of the Year 2026
Tailored for today's complex clinical trials, YPrime's platform helps patients remain engaged and compliant through straightforward design. Developed to integrate intelligently with other eClinical technologies and with the ability to move between devices, YPrime offers a customized solution with the necessary control and security that ensures accurate data collection from specification to submission.
"Real-time data access enhances project control for sponsors and empowers their decision-making," said Michael Hughes, senior vice president, product development. "With superior processing power and advanced security protections, clinical development teams can be assured that they'll receive continuous, high-quality data throughout the duration of the study."
About YPrime
YPrime's cloud-based technology streamlines clinical trial data collection and management. YPrime's eCOA and interactive response technology (IRT) platforms introduce greater speed, precision, and data quality to clinical trials. Our consulting services help clients simplify downstream processes, while moving faster and more efficiently to their next development milestone.
0 Comments
Latest on The PennZone
- Glenn Lyvers Wins 2nd Place in Arizona State Poetry Society 2026 Annual Contest
- Access Control Security Shares 5 Ways Retailers Can Prevent Holiday Theft
- Bountiful Bowl Aims to Raise $50,000 to Support Meals on Wheels of the Greater Lehigh Valley
- Extreme Lead Program Highlights $27 Real Human Traffic Test for Affiliate and Network Marketers
- Longevity Academy Features Gail Humble, MD of KLOTHO SKIN in the Longevity Leaders Project
- Datavalet Named One of Quebec's Best Workplaces™ for 2026
- Phinge Corporation Engages Sheridan Ross PC for Certain Intellectual Property Matters
- Alan Hamilton of Shiver Hamilton Campbell Inducted as a Fellow of the American College of Trial Lawyers
- Slotozilla Hosts Exclusive Halloween Casino Bonuses for 2026
- One Night. One Encounter. A New Season Of Purpose
- "BROOKLYN, BROOKLYN, BROOKLYN" children's book and official YouTube channel launch on October 27th
- Expanding Into Medically Supervised Wellness With Major Apollo Wellness Centers Announcement; Sibannac, Inc. (Stock Symbol: SNNC)
- Nextlink Internet Deploys netElastic to Modernize Its Hybrid Broadband Network
- Dynamic Relaunch as AI Predictive Cybersecurity Company Optimized to Prevent Threats Proactively: Cycurion, Inc. (N A S D A Q: CYCU)
- EMBER™ Unveils the Workplace Identity Score™ (WIS™), the First Standard for Measuring Workplace Impact on Workforce Performance & Business Growth
- With Oil Prices Surging…Sky Quarry's Nevada Refinery Is Back in Action — CEO Highlights a Powerful New Growth Chapter for (N A S D A Q: SKYQ)
- Preston Dermatology & Skin Surgery Center and Dr. Sheel Desai Solomon Win Gold in Raleigh's Best Awards for Second Consecutive Year
- We are Talker Study: 64% of AI Users Have Bought From a Brand AI Introduced, as The Invisible Shortlist Reshapes Brand Discovery
- One in three Americans may have lost track of retirement savings from a previous job
- Political Concerns Drive US Investors to Golden Visas